Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1APD334 L-arginine
(D02982)
[2] Arginine,
L-arginine
[3] Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--[1] 97 💬
2AR401959 L-arginine
(D02982)
[2] Arginine,
L-arginine
[3] Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--[3] 96, 97, 98 💬
3Arginine
(D02982)
[1] Arginine[3] Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--[16] 2, 21, 46, 57, 58, 67, 72, 96, 97, 98, 113, 210, 223, 225, 251, 299 💬
4Arginine and citrulline supplementations
(D02982)
[2] Arginine,
Citrulline
[5] Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride ,
L-Citrulline ,
Citrulline malate 💬
--[1] 21 💬
5Diagnostic Test: Deamino Arginine Vasopressin (dDAVP)
(D02982)
[2] Arginine,
Vasopressin
[4] Vasopressin ,
Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
[3] AVPR1A,
AVPR1B,
AVPR2 💬
[6] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬[1] 225 💬
6Etrasimod L-arginine
(D02982)
[3] Arginine,
Etrasimod,
L-arginine
[5] Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride ,
Etrasimod ,
Etrasimod arginine 💬
[3] S1PR1,
S1PR4,
S1PR5 💬
[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 96, 97, 98 💬
7EtrasimodProduct Code: APD334Pharmaceutical Form: TabletINN or Proposed INN: etrasimod L-arginineCAS Number: 1206123-97-8Current Sponsor code: APD334 L-arginine
(D02982)
[3] Arginine,
Etrasimod,
L-arginine
[5] Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride ,
Etrasimod ,
Etrasimod arginine 💬
[3] S1PR1,
S1PR4,
S1PR5 💬
[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 97 💬
8EtrasimodProduct Code: APD334Pharmaceutical Form: TabletINN or Proposed INN: etrasimod L-arginineCAS Number: 1206123-97-8Current Sponsor code: APD334 L-arginine PF-07915503-94 (L-arginine salt)Other descriptive name: AR401959 L-arginineConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 2-
(D02982)
[3] Arginine,
Etrasimod,
L-arginine
[5] Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride ,
Etrasimod ,
Etrasimod arginine 💬
[3] S1PR1,
S1PR4,
S1PR5 💬
[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 97 💬
9L-Arginine
(D02982)
[2] Arginine,
L-arginine
[3] Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--[10] 2, 21, 46, 67, 96, 97, 98, 113, 223, 299 💬
10Measure of arginine-stimulated copeptin
(D02982)
[1] Arginine[3] Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--[2] 72, 225 💬
11Ng-monomethyl-L-arginine (drug)
(D02982)
[2] Arginine,
L-arginine
[3] Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--[2] 67, 223 💬
12Peridopril arginine
(D02982)
[1] Arginine[3] Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--[1] 57 💬
13PERINDOPRIL ARGININE
(D02982)
[2] Arginine,
Perindopril
[6] Perindopril erbumine ,
Arginine hydrochloride ,
Arginine (D02982),
Perindopril ,
Arginine hydrochloride ,
Perindopril arginine 💬
[1] ACE 💬 [6] Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[2] 57, 58 💬
14PF-07915503-94 (L-arginine salt)Other descriptive name: AR401959 L-arginineConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 2-
(D02982)
[2] Arginine,
L-arginine
[3] Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--[1] 97 💬
15Vasopressin, Arginine
(D02982)
[2] Arginine,
Vasopressin
[4] Vasopressin ,
Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
[3] AVPR1A,
AVPR1B,
AVPR2 💬
[6] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬[1] 210 💬